Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 346

Do sin stocks really give your portfolio the edge?

Two recent papers looked at the historically strong performance (and recent weak performance) of what are known as ‘sin’ stocks. The analysis found that the stocks’ past outperformance (or alpha) was not as simple as reaping the rewards of a ‘deal with the devil’.

What are sin stocks?

‘Sin’ stocks are usually considered to be those whose activities are dominated by what would be considered unethical or immoral activity, usually alcohol, tobacco, gambling, adult entertainment and weapons.

We looked at two relevant papers covering the returns of such stocks:

  • Blitz, D. and F.J. Fabozzi. Sin Stocks Revisited: Resolving the Sin Stock Anomaly, 2017
  • Jorgensen, A. 'Sin' Stock Exclusions: What is the Impact?, UBS Global Research, October 2019

The data in both papers is drawn from Kenneth French’s data library and covers tobacco, alcohol and weapons.

Note that this approach identifies only the manufacturers of these goods, and indeed only firms for which manufacturing the product is their primary business.

Performance of sin stocks in history

Chart 1 below (from the UBS paper) shows that these stocks had very strong performance from the early 2000s to about 2016 or 2017. In fact, the data show that over the past 43 years, a cap-weighted benchmark of the largest 50 ‘sin’ stocks has outperformed the MSCI World by nearly 5% per year.

Chart 1: Sin stocks performance v benchmark: outperform the benchmark significantly and then sell-off over the last three years

The chart also plots the excess return of a portfolio of the MSCI World without these 50 names, to see what performance drag the portfolio would have had from excluding them. The answer is – very little. In fact, the portfolio of MSCI World, excluding the 50 sin stocks, only underperforms the MSCI World itself by about 6bps (0.06%) per year, as per Table 1.

Table 1: Summary statistics of portfolios of sin stocks, MSCI World (ex-sin stocks) and the MSCI World itself

The reason for this is clear – these stocks only actually represent a small component of the investible universe (a global average of 2.2%). Blitz and Fabozzi (2017) state that the size of these stocks in Developed Markets portfolios is not large: “… the combined weight of the sin sectors averages 2.1% for the United States, 3.5% for Europe, 1.6% for Japan, and 2.2% for global.” The UBS paper also notes that “… the low market capitalisation of these sectors means that, in practical terms, excluding them does not lead to significant change in performance.”

Recently, the outperformance of sin stocks has reversed, with a portfolio of 50 sin stocks down about 6% per year for 2017–2019.

Chart 2 (again from UBS) shows the stocks’ outperformance by broader sector categorisations, over a much longer horizon than Chart 1. The sin stock groupings here are alcohol, tobacco and weapons, which are easier to capture over a long period. All three sectors have participated in this alpha, with tobacco the best. The 1960–1990 period is truly remarkable, with the aggregate sin portfolio creating approximately 16 times the wealth of investing in the broader stock market.

Chart 2: Sin stocks outperformance by sector

Recent performance of sin stocks

As noted, Chart 3 shows that many sin stocks have sold off very strongly over the past three years. It appears the main drivers have been increased regulations, the rise of ‘vaping’ as a smoking alternative, and investors choosing to divest or exclude the stocks for ethical reasons.

Chart 3: Annual outperformance for each sector 2016-2019

Was there ever any alpha?

At first glance, the above charts would suggest that having an aggressive holding in these sectors would have delivered outperformance (alpha). However, the two papers agree conclusively that while apparent in simple excess return calculations, this alpha does not survive analysis when considering common factors such as size, value or momentum.

That is, there is no specific alpha in these names. The alpha is captured by well-known return factors, and so their factor exposure (and performance) could potentially be replicated by a portfolio of other (‘non-sin’) stocks.

The return factors used to capture any alpha (or detect unique insights) stem from the Fama and French class of models. The Blitz and Fabozzi paper, and the UBS analysis, both use the market return itself plus six other return premium factors:

  • Size: smallest stocks over largest stocks, by market cap
  • Value: cheapest stocks over most expensive stocks (measured using Book to Price)
  • Momentum: highest 12-month momentum stocks over lowest 12-month momentum stocks
  • Low beta (or ‘betting against beta’): Low beta stocks over high beta stocks
  • Profitability: highest profit margin stocks over lowest profit margin stocks
  • Investment (or ‘over investment’): lowest asset growth stocks over highest asset growth stocks

No sin in excluding these stocks

The observed outperformance is subsumed by a set of well-known return factors. Among other things, sin stocks seem to be low beta, are smaller than average and don’t seem to have a systematic value or momentum tilt. Sin stocks can be excluded from a portfolio without compromising potential performance.

 

David Walsh is Head of Investments at Realindex Investments, a wholly owned investment management subsidiary of First Sentier Investors, a sponsor of Firstlinks. This article is primarily for information. It discusses ideas that are important to the Realindex investment process and clients but may not be implemented in the ways discussed here.

For more articles and papers from First Sentier Investors, please click here.

 

banner

Most viewed in recent weeks

11 lessons from my lousy $50K profit on Afterpay

Afterpay listed at $1 in 2016 and traded recently at $70. How should an investor treat a small holding in a 70-bagger when each new level defies the experts? Should true believers let the profits run?

Which companies will do well in the turmoil of 2020?

While the shutting of Australia’s borders to international travellers and quarantine measures is damaging to certain sectors of the economy, it is not uniformly negative for all companies.

Why are we convinced 'this time it's different'?

Investors tend to overstate the impact on investments when something significant happens and they assume the future will be different. COVID-19 has been dramatic, but is it really that unusual?

Howard Marks' anatomy of an unexpected rally

Markets can swing quickly from optimism to pessimism, and while there are more positives now than in the bleak early days in March, the market is ignoring many negatives. Risk is not rewarded at these levels.

Welcome to Firstlinks Edition 363

The stock market continues to defy most equity pundits and push through fears of ongoing recession, job losses, business closures and a second virus wave. But if there's one factor in Australia specifically that is seriously underestimated, it is the loss of stimulus from population growth and immigration.

  • 25 June 2020

Welcome to Firstlinks Edition 364

Australian shares had their biggest annual loss for eight years in FY20 while Wall Street just had its best quarter since 1987. Whatever happens from here, we will look back in a couple of years and say the outcome was obvious. We will either say, "Of course markets rose as governments injected unlimited liquidity, medical science found treatments and the economy rebounded" or "Of course markets fell as businesses collapsed, millions of jobs were lost forever, the virus was resilient and consumers changed forever."

  • 1 July 2020

Latest Updates

Investment strategies

11 lessons from my lousy $50K profit on Afterpay

Afterpay listed at $1 in 2016 and traded recently at $70. How should an investor treat a small holding in a 70-bagger when each new level defies the experts? Should true believers let the profits run?

Shares

How did shares perform in FY20 and where to from here?

Compared with most years in the last decade, FY20 performed poorly due to the virus, and now dividends are falling. There are three things to watch this year as support policies are wound back.

Shares

Which companies will do well in the turmoil of 2020?

While the shutting of Australia’s borders to international travellers and quarantine measures is damaging to certain sectors of the economy, it is not uniformly negative for all companies.

Investment strategies

Six types of big data are unlocking real insights

Data science is increasingly embedded into the research process of investment teams with the resources to exploit new technologies. The way the data is integrated and interpreted is crucial.

Investing

Will value stocks benefit from the market's inflection point?

As the world gradually emerges from the aftermath of COVID-19, many are questioning if now is value’s time to shine? How can value stocks deliver outperformance in today’s environment?

Fixed interest

Less than 1% for 100 years: watch the price risk on long bonds

Do you think investors can only lose heavily on bonds if the credit defaults? When bondholders accept 0.88% for 100 years, there is great potential for serious pain somewhere along the journey.

Economy

Five industries profoundly changed by COVID-19

Even when the virus is finally contained, the business landscape will look very different. A critical issue is the ability of consumers to find product substitutes. Many people like what they find.

Exchange traded products

Wirecard shows not all ethical ETFs pass the smell test

The strictness of screening processes can vary between ethical ETFs, and many rely on indices without additional oversight. This can result in stock inclusions that may not pass the ethical ‘smell test’.

Sponsors

Alliances

© 2020 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use.
Any general advice or class service prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, has been prepared by without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.